Mettler-Toledo International (FRA:MTO) EPS without NRI: €37.36 (TTM As of Mar. 2026)


FRA:MTO Mettler-Toledo International Inc FRA:MTO
93 GF Score
Price €1,138.00
GF Value €1,247.13
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Mettler-Toledo International EPS without NRI?

Mettler-Toledo International FRA:MTO -0.09% 93 EPS without NRI is €37.36 as of Mar. 2026. GuruFocus rates FRA:MTO with a GF Score™ of 93/100 and a GF Value™ of €1,247.13 (Fairly Valued). The stock has 1 warning sign investors should review. Among 161 Medical Diagnostics & Research companies, Mettler-Toledo International ranks worse than 61.49% on this metric.

Mettler-Toledo International's earnings per share without non-recurring items for the three months ended in Mar. 2026 was €7.71. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was €37.36.

During the past 12 months, Mettler-Toledo International's average earnings per share (NRI) Growth Rate was 7.50% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 2.50% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 9.20% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 13.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Mettler-Toledo International's EPS without NRI or its related term are showing as below:

FRA:MTO' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0.8   Med: 14.85   Max: 395.2
Current: 2.5

During the past 13 years, Mettler-Toledo International's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 395.20% per year. The lowest was 0.80% per year. And the median was 14.85% per year.

FRA:MTO's 3-Year EPS without NRI Growth Rate is ranked worse than
61.49% of 161 companies
in the Medical Diagnostics & Research industry
Industry Median: 10.8 vs FRA:MTO: 2.50

Mettler-Toledo International's EPS (Diluted) for the three months ended in Mar. 2026 was €7.21. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €36.61.

Mettler-Toledo International's EPS (Basic) for the three months ended in Mar. 2026 was €7.22. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was €36.71.


Mettler-Toledo International  (FRA:MTO) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Mettler-Toledo International EPS without NRI Related Terms


Mettler-Toledo International EPS without NRI Historical Data

* Premium members only.

The historical data trend for Mettler-Toledo International's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mettler-Toledo International EPS without NRI Chart

Mettler-Toledo International Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.10 37.43 34.87 39.26 36.49

Mettler-Toledo International Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.58 8.75 9.50 11.41 7.71

FRA:MTO vs ILMN, DGX, LH: EPS without NRI Comparison

For the Diagnostics & Research subindustry, Mettler-Toledo International's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mettler-Toledo International PE Ratio without NRI vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Mettler-Toledo International's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Mettler-Toledo International's PE Ratio without NRI falls into.


FRA:MTO
93GF Score
Mettler-Toledo International Inc FRA:MTO
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mettler-Toledo International EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €37.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of €37.36 mean?
Mettler-Toledo International (FRA:MTO) has a EPS without NRI of €37.36 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Mettler-Toledo International and its competitors. According to the industry distribution chart, Mettler-Toledo International ranks #99 out of 161 companies in the Medical Diagnostics & Research industry, placing it in the top 61.5%.
Is Mettler-Toledo International's EPS without NRI too high?
Mettler-Toledo International's current EPS without NRI is €37.36. Based on the distribution chart, Mettler-Toledo International ranks #99 out of 161 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Mettler-Toledo International has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Mettler-Toledo International's EPS without NRI compare to ILMN and DGX?
According to the Medical Diagnostics & Research industry distribution chart, Mettler-Toledo International ranks #99 out of 161 companies for EPS without NRI. This places Mettler-Toledo International in the lower half of its industry. The industry median EPS without NRI is 10.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Diagnostics & Research company?
The median EPS without NRI among Medical Diagnostics & Research companies is 10.80, based on 161 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Mettler-Toledo International and its competitors. For the Medical Diagnostics & Research industry, the median EPS without NRI is 10.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mettler-Toledo International's current EPS without NRI is €37.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mettler-Toledo International stock overvalued right now?
Based on GuruFocus' analysis, Mettler-Toledo International (FRA:MTO) is currently considered Fairly Valued. The stock's GF Value™ is €1,247.13, compared to a current price of €1,138.00 — trading 8.8% below its estimated fair value. The current EPS without NRI is €37.36. Mettler-Toledo International's overall GF Score™ is 93/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Mettler-Toledo International (FRA:MTO), the current EPS without NRI is €37.36 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mettler-Toledo International (FRA:MTO) Overvalued in 2026?

Based on GuruFocus' analysis, Mettler-Toledo International stock appears to be undervalued. The current stock price of €1,138.00 is trading 8.8% below its estimated GF Value™ of €1,247.13. GuruFocus considers Mettler-Toledo International to be Fairly Valued.

Key valuation signals for FRA:MTO:

  • EPS without NRI: €37.36
  • GF Value™: €1,247.13 vs. price of €1,138.00 (8.8% below fair value)
  • GF Score™: 93/100 with 1 warning sign

No single metric tells the full story. See the FRA:MTO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Mettler-Toledo International Business Description

Address 1900 Polaris Parkway, Columbus, OH, USA, 43240
Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 27%, China about 16% and the rest of the world about 20%.
93GF Score

Get the complete analysis for FRA:MTO

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1,138.00
Price
€1,247.13
GF Value